Primary stenting for renal fibromuscular-dysplastic stenosis: A case report

European Review for Medical and Pharmacological Sciences

Volumn 13, Issue 4, 2009, Pages 317-319

  Cianci, R ^a   Stivali, G ^a   Gigante, A ^a   Donato, D D I ^a   Polidori, L ^a   Clemenzia, G ^a   Borghesi, F ^a   Renzulli, R ^a   Martina, P ^a   Gasperini, M L ^a   Barbano, Biagio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Color Doppler ultrasound; Fibromuscular dysplasia; Percutaneous transluminal angioplasty stenting; Renal artery; Renovascular hypertension

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; LOSARTAN; MANIDIPINE; TICLOPIDINE;

ANGIOGRAPHY; ARTICLE; BLOOD PRESSURE MONITORING; COLOR ULTRASOUND FLOWMETRY; FIBROMUSCULAR DYSPLASIA; FOLLOW UP; HOSPITAL DISCHARGE; HYPERTENSION; KIDNEY ARTERY STENOSIS; LABORATORY TEST; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVASCULARIZATION; STENT;

ADULT; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANGIOPLASTY, BALLOON; FEMALE; FIBROMUSCULAR DYSPLASIA; HUMANS; RENAL ARTERY OBSTRUCTION; STENTS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 69249122973     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. HARRISON EG JR, MCCORMACK LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc 1971; 46: 161-167.
2. BEGELMAN SM, OLIN JW. Fibromuscular dysplasia. Curr Opin Rheumatol 2000; 12: 41-47.
3. PRATAP T, SLOAND J, NARINS CR. Potential pitfalls of renal angiography: a case of atypical fibromuscular dysplasia. Angiology 2009; 59: 753-756.
4. SLOVUT DP, OLIN JW. Fibromuscular dysplasia. N Engl J Med 2004; 350: 1862-1871.
5. ZELLER T. Renal artery stenosis: epidemiology, clinical manifestation, and percutaneous endovascular therapy. J Interv Cardiol 2005; 18: 497-506.
6. VAN BOCKEL JH, WEIBULL H. Fibrodysplastic disease of the renal arteries. Eur J Vasc Surg 1994; 8: 655-657.
7. CLUZEL P, RAYNAUD A, BEYSSEN B, PAGNY JY, GAUX JC. Stenoses of renal branch arteries in fibromuscular dysplasia: results of percutaneous transluminal angioplasty. Radiology 1994; 193: 227-232.
8. VANMAELE RG, D'ARCHAMBEAU OC, VAN SCHIL PE, VAN LANDUYT KA, DE SCHEPPER AM. Ruptured balloon separation during percutaneous transluminal renal artery angioplasty. Eur J Vasc Surg 1993; 7: 104-106. (Pubitemid 23082819)
9. GAHLEN J, KOEPPEL T, PROSST RL. Vascular occlusion by ruptured balloon after percutaneous transluminal angioplasty. J Endovasc Ther 2003; 10: 1117-1119.
10. LÜSCHER TF, KELLER HM, IMHOF HG, GREMINGER P, KUHLMANN U, LARGIADÉR F, SCHNEIDER E, SCHNEIDER J, VETTER W. Fibromuscular hyperplasia: extension of the disease and therapeutic outcome: results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron 1986; 44: 109-114.
11. HÄGG A, ABERG H, ERIKSSON I, LÖRELIUS LE, MÖRLIN C. Fibromuscular dysplasia of the renal artery-management and outcome. Acta Chir Scand 1987; 153: 15-20. (Pubitemid 17038258)
12. SOS TA, PICKERING TG, SNIDERMAN K, SADDEKNI S, CASE DB, SILANE MF, VAUGHAN ED Jr, LARAGH JH. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983; 309: 274-279.
13. TOWBIN RB, PELCHOVITZ DJ, CAHILL AM, BASKIN KM, MEYERS KE, KAPLAN BS, MCCLAREN CA, ROEBUCK DJ. Cutting balloon angioplasty in children with resistant renal artery stenosis. J Vasc Interv Radiol 2007; 18: 663-669. (Pubitemid 46671577)